mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.05 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.06 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.06 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |